These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Metabolic syndrome in men with low testosterone levels: relationship with cardiovascular risk factors and comorbidities and with erectile dysfunction. García-Cruz E; Leibar-Tamayo A; Romero J; Piqueras M; Luque P; Cardeñosa O; Alcaraz A J Sex Med; 2013 Oct; 10(10):2529-38. PubMed ID: 23898860 [TBL] [Abstract][Full Text] [Related]
4. Association between red meat consumption and metabolic syndrome in a Mediterranean population at high cardiovascular risk: cross-sectional and 1-year follow-up assessment. Babio N; Sorlí M; Bulló M; Basora J; Ibarrola-Jurado N; Fernández-Ballart J; Martínez-González MA; Serra-Majem L; González-Pérez R; Salas-Salvadó J; Nutr Metab Cardiovasc Dis; 2012 Mar; 22(3):200-7. PubMed ID: 20875949 [TBL] [Abstract][Full Text] [Related]
5. Risk factors of metabolic syndrome among hypertensive patients at Hawassa University Comprehensive Specialized Hospital, Southern Ethiopia. Tadewos A; Egeno T; Amsalu A BMC Cardiovasc Disord; 2017 Aug; 17(1):218. PubMed ID: 28789613 [TBL] [Abstract][Full Text] [Related]
6. CA.ME.LI.A. An epidemiological study on the prevalence of CArdiovascular, MEtabolic, LIver and Autoimmune diseases in Northern Italy. Bignotto M; Dei Cas M; Paroni R; Bianco E; Zermiani P; Gangale MG; Zadro V; Maregatti M; Piagnani A; Russo A; Baldassarre D; Folli F; Battezzati PM; Zuin M Nutr Metab Cardiovasc Dis; 2021 May; 31(5):1416-1426. PubMed ID: 33814235 [TBL] [Abstract][Full Text] [Related]
7. Cardiovascular risk in different obesity phenotypes over a decade follow-up: Tehran Lipid and Glucose Study. Mirzaei B; Abdi H; Serahati S; Barzin M; Niroomand M; Azizi F; Hosseinpanah F Atherosclerosis; 2017 Mar; 258():65-71. PubMed ID: 28213199 [TBL] [Abstract][Full Text] [Related]
8. Prospective Study of Nut Consumption and Incidence of Metabolic Syndrome: Tehran Lipid and Glucose Study. Hosseinpour-Niazi S; Hosseini S; Mirmiran P; Azizi F Nutrients; 2017 Sep; 9(10):. PubMed ID: 28946607 [TBL] [Abstract][Full Text] [Related]
9. Indicators of Cardiovascular Risk in Metabolic Syndrome: Long Term Follow-up in Italian Patients. Mombelli G; Pavanello C; Castelnuovo S; Bosisio R; Simonelli S; Pazzucconi F; Sirtori CR Curr Vasc Pharmacol; 2017; 15(3):248-256. PubMed ID: 28128067 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of cardiovascular risk factors in long-term survivors of childhood cancer: 16 years follow up from a prospective registry. Felicetti F; D'Ascenzo F; Moretti C; Corrias A; Omedè P; Marra WG; Arvat E; Fagioli F; Brignardello E; Gaita F Eur J Prev Cardiol; 2015 Jun; 22(6):762-70. PubMed ID: 24691151 [TBL] [Abstract][Full Text] [Related]
12. Normal fasting plasma glucose predicts type 2 diabetes and cardiovascular disease in elderly population in Taiwan. Huang CL; Chang HW; Chang JB; Chen JH; Lin JD; Wu CZ; Pei D; Hung YJ; Lee CH; Chen YL; Hsieh CH QJM; 2016 Aug; 109(8):515-22. PubMed ID: 26576838 [TBL] [Abstract][Full Text] [Related]
13. Sex-specific clustering of metabolic risk factors and their association with incident cardiovascular diseases: A population-based prospective study. Ramezankhani A; Azizi F; Hadaegh F; Eskandari F Atherosclerosis; 2017 Aug; 263():249-256. PubMed ID: 28683364 [TBL] [Abstract][Full Text] [Related]
14. Obesity and incidence of diabetes: Effect of absence of metabolic syndrome, insulin resistance, inflammation and fatty liver. Sung KC; Lee MY; Kim YH; Huh JH; Kim JY; Wild SH; Byrne CD Atherosclerosis; 2018 Aug; 275():50-57. PubMed ID: 29860108 [TBL] [Abstract][Full Text] [Related]
15. Relationships among insulin resistance, obesity, diagnosis of the metabolic syndrome and cardio-metabolic risk. Salazar MR; Carbajal HA; Espeche WG; Dulbecco CA; Aizpurúa M; Marillet AG; Echeverría RF; Reaven GM Diab Vasc Dis Res; 2011 Apr; 8(2):109-16. PubMed ID: 21562062 [TBL] [Abstract][Full Text] [Related]
16. Seasonal pattern in bipolar disorders and cardio-vascular risk factors: A study from the FACE-BD cohort. Geoffroy PA; Godin O; Mahee D; Henry C; Aubin V; Azorin JM; Bougerol T; Courtet P; Gard S; Kahn JP; Passerieux C; Leboyer M; Bellivier F; Etain B; Chronobiol Int; 2017; 34(7):845-854. PubMed ID: 28537802 [TBL] [Abstract][Full Text] [Related]
18. Impaired Fasting Glucose Is the Major Determinant of the 20-Year Mortality Risk Associated With Metabolic Syndrome in Nondiabetic Patients With Stable Coronary Artery Disease. Younis A; Goldkorn R; Goldenberg I; Geva D; Tzur B; Mazu A; Younis A; Fisman Z; Tannenbaum A; Klempfner R J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29079562 [TBL] [Abstract][Full Text] [Related]
19. The metabolic syndrome predicts cardiovascular events in subjects with normal fasting glucose: results of a 15 years follow-up in a Mediterranean population. Noto D; Barbagallo CM; Cefalù AB; Falletta A; Sapienza M; Cavera G; Amato S; Pagano M; Maggiore M; Carroccio A; Notarbartolo A; Averna MR Atherosclerosis; 2008 Mar; 197(1):147-53. PubMed ID: 17466306 [TBL] [Abstract][Full Text] [Related]
20. Impaired fasting glucose, ancestry and waist-to-height ratio: main predictors of incident diagnosed diabetes in the Canary Islands. de León AC; Coello SD; González DA; Díaz BB; Rodríguez JC; Hernández AG; Aguirre-Jaime A; Pérez Mdel C Diabet Med; 2012 Mar; 29(3):399-403. PubMed ID: 21883429 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]